loadpatents
Patent applications and USPTO patent grants for Mimoto; Futa.The latest application filed is for "antigen-binding molecule containing modified fc region".
Patent | Date |
---|---|
Antigen-binding Molecule Containing Modified Fc Region App 20220242934 - Igawa; Tomoyuki ;   et al. | 2022-08-04 |
Fc region variant Grant 11,267,868 - Mimoto , et al. March 8, 2 | 2022-03-08 |
Mouse Fc.gamma.ammaRII-specific Fc antibody Grant 11,236,168 - Igawa , et al. February 1, 2 | 2022-02-01 |
Anti-cd137 Antigen-binding Molecule And Utilization Thereof App 20210324099 - IGAWA; Tomoyuki ;   et al. | 2021-10-21 |
Antigen-binding molecule containing modified Fc region Grant 11,142,563 - Igawa , et al. October 12, 2 | 2021-10-12 |
Method for producing polypeptide heteromultimer Grant 11,124,576 - Igawa , et al. September 21, 2 | 2021-09-21 |
FCgammaRIIB-SPECIFIC FC REGION VARIANT App 20210261648 - Katada; Hitoshi ;   et al. | 2021-08-26 |
FcgammaRIIB-specific Fc region variant Grant 10,919,953 - Katada , et al. February 16, 2 | 2021-02-16 |
Antigen-binding Molecule And Combination App 20200399373 - IGAWA; Tomoyuki ;   et al. | 2020-12-24 |
Heterodimerized polypeptide Grant 10,766,960 - Igawa , et al. Sep | 2020-09-08 |
Method For Altering Plasma Retention And Immunogenicity Of Antigen-binding Molecule App 20200199241 - Igawa; Tomoyuki ;   et al. | 2020-06-25 |
MODIFIED Fc REGION OF ANTIBODY App 20200181257 - Kuramochi; Taichi ;   et al. | 2020-06-11 |
Method for altering plasma retention and immunogenicity of antigen-binding molecule Grant 10,618,965 - Igawa , et al. | 2020-04-14 |
Antibody constant region variants with reduced Fcgammar binding Grant 10,435,458 - Kuramochi , et al. O | 2019-10-08 |
THERAPEUTIC ANTIGEN-BINDING MOLECULE WITH A FcRn-BINDING DOMAIN THAT PROMOTES ANTIGEN CLEARANCE App 20190233525 - Igawa; Tomoyuki ;   et al. | 2019-08-01 |
Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen clearance Grant 10,253,100 - Igawa , et al. | 2019-04-09 |
Heterodimerized Polypeptide App 20180155451 - Mimoto; Futa ;   et al. | 2018-06-07 |
Heterodimerized polypeptide Grant 9,890,218 - Mimoto , et al. February 13, 2 | 2018-02-13 |
Method For Producing Polypeptide Heteromultimer App 20160229915 - Igawa; Tomoyuki ;   et al. | 2016-08-11 |
Antigen-Binding Molecule for Promoting Disappearance of Antigen via Fc gamma RIIB App 20160046693 - Igawa; Tomoyuki ;   et al. | 2016-02-18 |
Fc REGION VARIANT App 20160039912 - Mimoto; Futa ;   et al. | 2016-02-11 |
Heterodimerized Polypeptide App 20150344570 - Igawa; Tomoyuki ;   et al. | 2015-12-03 |
FCgammaRIIB-SPECIFIC FC REGION VARIANT App 20150299296 - Katada; Hitoshi ;   et al. | 2015-10-22 |
MODIFIED Fc REGION OF ANTIBODY App 20150210763 - Kuramochi; Taichi ;   et al. | 2015-07-30 |
MOUSE FcgammaRII-SPECIFIC Fc ANTIBODY App 20150203577 - Igawa; Tomoyuki ;   et al. | 2015-07-23 |
Antigen-binding Molecule Containing Modified Fc Region App 20150166636 - Igawa; Tomoyuki ;   et al. | 2015-06-18 |
THERAPEUTIC ANTIGEN-BINDING MOLECULE WITH A FcRn-BINDING DOMAIN THAT PROMOTES ANTIGEN CLEARANCE App 20140363428 - Igawa; Tomoyuki ;   et al. | 2014-12-11 |
Heterodimerized Polypeptide App 20140199294 - Mimoto; Futa ;   et al. | 2014-07-17 |
Method For Altering Plasma Retention And Immunogenicity Of Antigen-binding Molecule App 20140105889 - Igawa; Tomoyuki ;   et al. | 2014-04-17 |
Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY App 20140093496 - Mimoto; Futa ;   et al. | 2014-04-03 |
Antibody Constant Region Variant App 20130101581 - Kuramochi; Taichi ;   et al. | 2013-04-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.